(Q39776282)

English

Current practices for DNA sample collection and storage in the pharmaceutical industry, and potential areas for harmonization: perspective of the I-PWG.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Current practices for DNA sample collection and storage in the pharmaceutical industry, and potential areas for harmonization: perspective of the I-PWG. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

M A Franc

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

A W Warner

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

N Cohen

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

P M Shaw

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

P Groenen

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

A Snapir

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

0 references

publication date

2 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

89

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

546-553

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Pharmacogenomic biomarkers for prediction of severe adverse drug reactions

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.338

21 January 2018

Pharmacogenetics and drug development: the path to safer and more effective drugs

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.338

21 January 2018

Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.338

21 January 2018

Pharmacogenomics: bench to bedside

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.338

21 January 2018

Potential harms, anonymization, and the right to withdraw consent to biobank research

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.338

21 January 2018

Returning genetic research results to individuals: points-to-consider

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.338

21 January 2018

Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.338

21 January 2018

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.338

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.338

21 January 2018

Identifiers

10.1038/CLPT.2010.338

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

release_gbwcehv7xvdkppfpfnixgdq5wa

1 reference

https://api.fatcat.wiki/v0/release/gbwcehv7xvdkppfpfnixgdq5wa

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39776282&oldid=2090221669"